ECG INTERPRETATION AMONG COVID-19 PATIENTS

Abstract

Background: The goal was to use surface electrocardiographic (ECG) indicators to detect COVID-19's malignant arrhythmic potential.

Methodology: In 51 COVID-19 patients and 40 control subjects, the ECG parameters PR, QT, QTc, QTd, TPe, and Tpe/QTc were assessed. COVID-19 patients had substantially higher mean QTc (410.8 24.3 msec vs. 394.6 20.3 msec, p.001), Tpe/QTc (0.19 0.02 vs. 0.18 0.04, p =.036), and median QTd (47.52 vs. 46.5) values than the control group. Troponin levels were linked with heart rate (r = 0.387, p =.006) but not with ECG parameters (r = 0.387, p =.006).

Conclusion: In Covid19 patients, several ventricular arrhythmia surface ECG predictors, such as QTc, QTd, and Tpe/QTc, are elevated. Because drugs used in COVID-19 patients have the potential to impact these parameters.

Keywords: Malignant arrhythmia, COVID-19, QT prolongation ECG.